- Research article
- Open Access
Similarities and differences between rat and mouse chondrocyte gene expression induced by IL-1β
Journal of Orthopaedic Surgery and Research volume 17, Article number: 70 (2022)
Osteoarthritis (OA) is the most prevalent degenerative joint disease. In vitro experiments are an intuitive method used to investigate its early pathogenesis. Chondrocyte inflammation models in rats and mice are often used as in vitro models of OA. However, similarities and differences between them in the early stages of inflammation have not been reported.
This paper seeks to compare the chondrocyte phenotype of rats and mice in the early inflammatory state and identify chondrocytes suitable for the study of early OA.
Under similar conditions, chondrocytes from rats and mice were stimulated using the same IL-1β concentration for a short period of time. The phenotypic changes of chondrocytes were observed under a microscope. The treated chondrocytes were subjected to RNA-seq to identify similarities and differences in gene expression. Chondrocytes were labelled with EdU for proliferation analysis. Cell proliferation-associated proteins, including minichromosome maintenance 2 (MCM2), minichromosome maintenance 5 (MCM5), Lamin B1, proliferating cell nuclear antigen (PCNA), and Cyclin D1, were analysed by immunocytochemical staining, cell immunofluorescence, and Western blots to verify the RNA-seq results.
RNA-seq revealed that the expression patterns of cytokines, chemokines, matrix metalloproteinases, and collagen were similar between the rat and mouse chondrocyte inflammation models. Nonetheless, the expression of proliferation-related genes showed the opposite pattern. The RNA-seq results were further verified by subsequent experiments. The expression levels of MCM2, MCM5, Lamin B1, PCNA, and Cyclin D1 were significantly upregulated in rat chondrocytes (P < 0.05) and mouse chondrocytes (P < 0.05).
Based on the findings, the rat chondrocyte inflammation model may help in the study of the early pathological mechanism of OA.
Osteoarthritis (OA) is a common chronic disease-causing type of articular cartilage degeneration. The World Health Organization approximates that 9.6% of men and 18% of women over 60 years of age are in the early stages of OA pathogenesis [1, 2]. China has a high OA prevalence, and its burden is substantial [3, 4]. OA progression is clinically slow and unpredictable, and related clinical studies focus on the middle and late stages of the disease. As a result, these findings may not reflect the molecular events and structural changes of the joints in an accurate and timely manner [5, 6]. Early OA pathogenesis is the most vital stage but is often ignored and not fully understood [7, 8]. Since it is relatively difficult to obtain clinical samples, animal models of OA are often used for alternative research . Nevertheless, animal experiments are time-consuming with many uncontrollable factors .
In contrast with the more complex in vivo experiments, in vitro experiments are direct and convenient in studying early disease pathogenesis . To better explore the pathological mechanism of early OA, we searched the literature related to in vitro experiments on OA. Rat and mouse chondrocytes were more often selected as study subjects than human chondrocytes (Additional file 4: Fig. S1). Moreover, several studies have used IL-1β to simulate the OA environment in chondrocytes to assess the pathological mechanism of OA [12, 13]. The chondrocytes were from either rats or mice, and the intervention conditions were similar. Because of the species differences between rats and mice, we sought to identify whether chondrocytes from different species exhibit different performances after induction with similar IL-1β concentrations for a short period of time.
This work aims to compare and confirm similarities and differences in gene expression between rat and mouse chondrocytes under similar inflammatory induction conditions. This report is geared towards a simple and appropriate in vitro inflammatory model for the study of the early pathological mechanism of OA.
Sprague–Dawley (SD) rats and C57BL/6 mice were purchased from Shanghai Xipur-Bikai Experimental Animal Co., Ltd. (Shanghai, China). All the experimental animals were sacrificed through decapitation after inhaling diethyl ether.
Isolation, culture, and intervention of chondrocytes
The primary culture of chondrocytes was performed according to the published literature . Chondrocytes were isolated from the articular cartilage of newborn rats and mice (24 h old) and then dispersed in 0.1% collagenase type II (C6885, Sigma-Aldrich, Switzerland) in a shaker at 37 °C for 3 h. The chondrocytes were collected and cultured in Dulbecco’s modified Eagle’s medium (DMEM, Biowest, France) supplemented with 10% FBS (Biowest, France) and 1% penicillin–streptomycin. Chondrocytes at passage 1 were used in all experiments to prevent chondrocyte dedifferentiation during long-term in vitro expansion .
The chondrocytes of rats and mice were divided into the control group (RC = rat control group, MC = mouse control group) and model group (RM = rat model group, MM = mouse model group). The chondrocytes in the model groups were stimulated with 20 ng/ml IL-1β (R&D Company) for 24 h and extracted for sequencing.
RNA-seq and data analysis
RNA samples for sequencing were extracted from three independent samples of each group to reduce individual differences. A total amount of 1.5 µg RNA extract was used, and cDNA library construction and RNA-seq (Illumina HiSeq 4000) were performed by Shanghai Life Genes Technology Co., Ltd. An RNA integrity number (RIN) > 8 confirmed the integrity of the RNA. RNA integrity was evaluated using the RNA Nano 6000 Assay Kit of the Bioanalyzer 2100 system (Agilent Technologies, CA, USA). Sequencing libraries were generated using the NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (NEB, USA). For selection of appropriately sized cDNA fragments, the library fragments were purified using the AMPure XP system (Beckman Coulter, Beverly, USA). Finally, library quality was assessed on the Agilent Bioanalyzer 2100 system. After sequencing, the data from different groups were analysed.
The network of common genes and the KEGG pathways were drawn using Cytoscape 3.6.1. A sample with a fold change greater than 0.85, P value less than 0.05, and at least one fragment per kilobase million (FPKM) ≥ 1 (excluding low expression genes) was considered an effective differentially expressed gene (DEG). DEGs were also annotated in GO and KEGG databases to detect gene functions and pathways. Notably, high-throughput sequencing data are available through the GEO database with the access number GSE163080.
EdU (5-ethynyl-2′-deoxyuridine) assay
Chondrocytes of each group were seeded in 6-well plates at a density of 3 × 105 cells/well. The proliferative capability of the chondrocytes was detected by a BeyoClick™ EdU Cell Proliferation Kit with DAB (Beyotime, Shanghai, China). The experimental process strictly followed the manufacturer’s instructions. The nuclei were detected using DAPI staining solution (Cat. No. A1001, Aleichem, Germany). After the cells were washed in PBS, they were observed under an inverted microscope (Olympus IX73, Tokyo, Japan). Three technical repeated experiments were conducted in each group.
Chondrocytes of each group were seeded in 6-well plates at a density of 3 × 105 cells/well, fixed on slides with 4% paraformaldehyde at room temperature for 30 min, and then rinsed using phosphate buffer (PBS). The cells were incubated using 0.1% Triton X-100 for 20 min, followed by PBS rinsing. Chondrocytes were incubated with 5% bovine serum albumin at 37 °C for 20 min and then incubated overnight with primary antibody against MCM2 (A5172, Bimake, China) at 4 °C. The cells were then washed with PBS three times and incubated with a secondary antibody in 1% BSA for 30 min at RT. Diaminobenzidine (DAB) was used as a substrate for colour development. The nuclei were stained using 10 ng/ml DAPI (Cat. No. A1001, Aleichem, Germany) to mark all cells; they were observed under an inverted microscope.
Chondrocytes were seeded onto coverslips and maintained in complete DMEM medium or complete DMEM medium plus IL-1β for 24 h. The culture medium was discarded, and the coverslips were rinsed twice with PBS pH 7.4. The cells were fixed with 4% paraformaldehyde, washed three times using PBS, permeabilized with 0.1% Triton X-100 in PBS for 30 min at room temperature (RT), and washed with PBS three times. Thereafter, the cells were incubated in PBST with 10% BSA for 60 min to block nonspecific antibody binding, incubated with primary MCM5 antibody (A5489, Bimake, China) in 1% BSA for 60 min at RT, washed with PBS three times, and incubated with a secondary antibody in 1% BSA for 30 min at RT. The nuclei were stained using 10 ng/ml DAPI (Cat. No. A1001, Aleichem, Germany).
Chondrocytes were collected in lysis buffer (Beyotime, P0013B) containing protease inhibitor (PMSF). The lysates were centrifuged at 12,000×g at 4 °C for 10 min. Protein concentrations were measured using a BCA Protein Assay Kit (Cat. No. 23227, Pierce, USA). SDS-PAGE (15%) was used to separate the proteins and transferred to PVDF membranes based on a standard protocol. These membranes were incubated with primary antibodies and probed with the corresponding secondary antibodies. Protein visualization was conducted using enhanced chemiluminescence (Pierce Biotechnology, Rockford, USA). The following antibodies were utilized: PCNA (A5324, Bimake, China), Cyclin D1 (A5035, Bimake, China), and GAPDH (#2118, CST, USA).
Statistical analyses were performed using SPSS 20.0 software (IBM SPSS, Inc., Chicago, IL, USA). The data are expressed as the mean ± standard deviation. Data between the two groups were compared using an unpaired t test. All data are normally distributed. When the sample size was 3, the sample power was 0.9832. Cohen's D statistic was used to test the effect size (ES), and the ES value was 4.47. GraphPad Prism 8.0 (GraphPad Software San Diego, CA) was applied for data drawing. P < 0.05 was considered statistically significant.
The expression of common genes and KEGG pathways in rat and mouse chondrocytes by enrichment analysis
The methodology of this study is summarized in Fig. 1. After sequencing, 13,919 genes were shared by rats and mice. Of these, 721 genes had significantly upregulated expression in the RM group, while 1932 genes had significantly upregulated expression in the MM group. Moreover, 709 genes had significantly downregulated expression in the RM group, and 2247 genes w had significantly downregulated expression in the MM group. By taking the intersection of genes, we found that 288 genes had upregulated expression, while 347 genes had downregulated expression in both the rat and mouse model groups. Notably, 635 genes showed a similar expression pattern (Fig. 2A; Additional file 1: Table S1). Through KEGG pathway enrichment analysis, 5 enriched signalling pathways were selected and sorted by P value: the TNF signalling pathway, IL-17 signalling pathway, cytokine-cytokine receptor interaction, and other signalling pathways (Table 1). Among the 5 signalling pathways, 76 genes, including cytokines (IL-1, IL-6, IL-13, and IL-18), chemokines (CXCL1, CXCL2, CXCL3, and CXCL16), matrix metalloproteinases (MMP3, MMP9, and MMP13), and collagen (Col1a1, Col1a2, Col2a1, Col9a1, Col9a2, and Col9a3), were primarily involved (Fig. 2B). In both the rat and mouse model groups, the expression of cytokines, chemokines, and matrix metalloproteinases was upregulated, whereas the expression of collagen was downregulated.
Morphological and proliferative differences in rat and mouse chondrocytes
The results showed that the chondrocytes in the RC and MC groups were polygonal, typical characteristics of chondrocytes. The chondrocytes in the RM and MM groups revealed degenerative and long fusiform changes. The cell density in the RM group was significantly higher than that in the RC group. In contrast, the cell density in the MM group was dramatically lower than that in the MC group (Fig. 3A).
EdU staining showed that the number and rate of EdU-positive cells in the RM group were significantly higher than those in the RC group. In mouse chondrocytes, EdU staining presented conflicting results, e.g. the number and rate of EdU-positive cells in the MM group were significantly lower than those in the MC group (Fig. 3B).
Differentially expressed genes (DEGs) in RNA-Seq data of rat and mouse chondrocytes
To investigate the differences in gene expression profiles that regulate chondrocyte proliferation, we analysed the RNA-seq results of rat and mouse chondrocytes.
First, the volcanic map showed the differences of 13,919 genes in mRNA expression between the model group and control group in each species (Fig. 4A). Through statistical analysis, this study found 4083 genes with inconsistent expression in the RM and MM groups. Among them, 171 genes had significantly upregulated expression in the RM group and downregulated expression in the MM group. Additionally, 85 genes had significantly downregulated expression in the RM group and upregulated expression in the MM group. In addition, 3288 genes without a significant difference in the RM group had a significant difference in the MM group, whereas 539 genes had no significant difference in the MM group but had a significant difference in the RM group. Therefore, 4083 DEGs were found in rats and mice (Fig. 4B; Additional file 2: Table S2).
GO and KEGG pathway enrichment analysis of differentially expressed genes (DEGs)
The differences in the proliferation of the RM and MM groups may be related to these DEGs. As such, these DEGs in rats and mice were further analysed through GO and KEGG pathway enrichment analysis. GO functional classification was conducted to explore the function of annotated genes. In rats and mice, the terms “cellular process”, “biological regulation” and “regulation of biological process”; “cell”, “cell part”, and “organelle”; “binding”, “catalytic activity” and “molecular function regulator” were the most representative of biological process, cellular component and molecular function, respectively (Fig. 5A).
The significant pathways of the DEGs were established by KEGG pathway enrichment analysis. Based on the classification results, 168 DEGs between rats and mice belonged to the category of "cell growth and death" in the category of "cell process"; the signalling pathways in this category were closely related to cell proliferation (Fig. 5B). Among the top five signalling pathways in rats and mice according to the P value, only the "cell cycle" belonged to this category (Fig. 5C; Table 2). The 52 DEGs belonging to the "cell cycle" signalling pathway in rats and mice are shown by hierarchical clustering of a heatmap and include MCM2, MCM5, Lamin B1, PCNA, and Cyclin D1. (Fig. 5D; Additional file 3: Table S3).
Validation of proliferation-related protein expression in chondrocytes
The above five DEGs highly correlated with cell proliferation were selected for analysis to validate the RNA-seq results. The expression levels of MCM2 and MCM5 were detected via immunocytochemistry or immunofluorescence, respectively. The results revealed that, unlike their respective controls, the expression levels of these two proteins were significantly upregulated in the RM group but remarkably downregulated in the MM group (Fig. 6A, B).
As shown in Fig. 6C, IL-1β downregulated the expression levels of Lamin B1, PCNA, and Cyclin D1 in mouse chondrocytes, while upregulating the expression levels of Lamin B1, PCNA, and Cyclin D1 in rat chondrocytes.
Primary chondrocytes isolated from rat or mouse articular cartilage are often used as research objects in experiments in vitro. Therefore, to accurately construct in vitro inflammation models for the study of early OA, we need to explore the differences between in vitro inflammation models of rat and mouse chondrocytes.
This study found that the expression patterns of related cytokines, chemokines, matrix metalloproteinases, and collagen were consistent between rat and mouse chondrocyte inflammatory models after RNA-seq. Notably, genes are biological markers that directly reflect the biosynthesis and catabolism of chondrocytes in OA progression. For instance, interleukins are inflammatory cytokines, and IL-1, IL-6, and IL-18 are proinflammatory factors [16, 17], while IL-13 is an anti-inflammatory factor . Additionally, CXCL1, CXCL2, CXCL3, and CXCL16 belong to the CXC chemokine subfamily . Inflammatory cytokines and chemokines are vital molecules in OA pathogenesis. In the chondrocytes of patients with OA, the content of these cytokines increased to varying degrees; therefore, their expression changes are used as a reference index to establish the inflammatory state in OA development [20,21,22].
MMP-3 and MMP-13 are matrix metalloproteinases (MMPs); they are the primary collagenases for cartilage degradation and are closely related to the pathological changes of OA [23, 24]. Type I collagen is a marker of fibrocartilage and exists throughout the development of OA; type II collagen is the most important collagen in articular cartilage and supports articular cartilage tissue. Moreover, type IX collagen plays a crucial role in the tissue and stability of the cartilage extracellular matrix [25,26,27]. By analysing RNA-seq results, all these genes, including inflammatory factors, chemokines, matrix metalloproteinases, and collagen, revealed a similar expression trend in the presence of IL-1β. Therefore, based on the biosynthesis and metabolism of cartilage in OA progression, no difference was noted between the inflammatory model of rat chondrocytes and mouse chondrocytes.
Rat and mouse chondrocyte inflammatory models have similar manifestations in the expression trend of the genes described above under similar conditions, including cell seeding density, IL-1β concentration, and shorter intervention time. However, rat chondrocytes showed significant increases, and mouse chondrocytes showed significant decreases.
To explore the reason, we further analysed and mined the sequencing results. Consequently, 52 genes were closely related to proliferation. Based on the functional GO categorizations, these genes are mainly implicated in cell metabolism. Furthermore, these genes were primarily concentrated in the "cell cycle" signal pathway belonging to "cell growth and death" via KEGG pathway enrichment analysis.
The related genes involved in the regulation of the "cell cycle" also directly regulate the proliferation of chondrocytes in rats and mice, as the genes included MCM2, MCM5, PCNA, Cyclin D1 and Lamin B1 [28,29,30,31,32]. The protein expression levels of MCM2, MCM5, Lamin B1, PCNA, and Cyclin D1 were significantly upregulated in the RM group and remarkably downregulated in the MM group. These findings further verify the RNA-seq results. Our results show that in a short time, a similar IL-1β concentration had the opposite effect on the proliferation of rat and mouse articular chondrocytes. That is, the same inflammatory stimulation conditions promoted the proliferation of rat chondrocytes in a short time period while inhibiting the proliferation of mouse chondrocytes.
Previous studies used IL-1β to stimulate rat chondrocytes and observed their proliferation. The proliferation of rat chondrocytes was significantly inhibited [33, 34]. These findings conflicted with our results. To explore the underlying mechanism, we passaged the chondrocytes used in these studies numerous times or cultured them in vitro for a prolonged period. Chondrocytes may be dedifferentiated, losing their proliferative capacity. Based on OA samples from surgery, chondrocytes from OA cartilage are usually in the middle and late stages of OA . At this stage, the catabolism of chondrocytes is accelerated, and chondrocytes are prone to cellular senescence after culturing in vitro.
Nevertheless, in the early stage of OA, the local loss of cartilage surface proteoglycan and the cleavage of type II collagen trigger a transient increase in chondrocyte proliferation and metabolic activity [36, 37]; unlike healthy chondrocytes, OA chondrocytes have a higher cell proliferation rate [38,39,40]. Moreover, proliferated human chondrocytes show fibroblast-like morphology and synthesize little extracellular matrix . Therefore, based on the above results of chondrocyte proliferation, extracellular matrix synthesis, and chondrocyte morphology, the rat chondrocyte inflammation model is more suitable to simulate the cartilage inflammation state in the early stage of OA than the mouse chondrocyte inflammation model. In addition, the corresponding research findings are more reliable.
This study has compelling limitations. First, we only explored and compared in vitro inflammatory models of rat and mouse chondrocytes, yet they have not been simultaneously compared with inflammatory models of human chondrocytes. As such, based on the available relevant findings, we can only speculate that the rat chondrocyte inflammation model is more suitable for early OA-related studies. In future research, we should establish additional species of early chondrocyte inflammation models and compare them with human chondrocytes in early OA. This analysis will provide more reliable inflammation models for early OA in vitro experiments.
In conclusion, the expression of cytokines, chemokines, matrix metalloproteinases, and collagen in rat and mouse chondrocyte inflammation models was similar under similar inflammatory stimulation for a short period of time. However, considerable differences were noted in cell proliferation. Therefore, based on our results, the rat chondrocyte inflammation model may help in the study of the early pathological mechanism of OA.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Minichromosome maintenance 2
Minichromosome maintenance 5
Proliferating cell nuclear antigen
Rat control group
Mouse control group
Rat model group
Mouse model group
RNA integrity number
Fragments per kilobase million
Differentially expressed gene
Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–56.
Poulet B, Beier F. Targeting oxidative stress to reduce osteoarthritis. Arthritis Res Ther. 2016;18:32. https://doi.org/10.1186/s13075-015-0908-7.
Xu B, Ye J, Yuan FZ, et al. Advances of stem cell-laden hydrogels with biomimetic microenvironment for osteochondral repair. Front Bioeng Biotechnol. 2020;8:247. https://doi.org/10.3389/fbioe.2020.00247.
Li HZ, Lin Z, Xu XH, Lin N, Lu HD. The potential roles of circRNAs in osteoarthritis: a coming journey to find a treasure. 2018. Biosci Rep. https://doi.org/10.1042/BSR20180542.
Beard DJ, Davies LJ, Cook JA, et al. The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial. Lancet. 2019;394(10200):746–56. https://doi.org/10.1016/S0140-6736(19)31281-4.
Tesche F, Miosge N. Perlecan in late stages of osteoarthritis of the human knee joint. Osteoarthritis Cartil. 2004;12(11):852–62. https://doi.org/10.1016/j.joca.2004.07.004.
Li H, Wang D, Yuan Y, Min J. New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis. Arthritis Res Ther. 2017;19(1):248. https://doi.org/10.1186/s13075-017-1454-2.
Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol. 2016;12(2):92–101. https://doi.org/10.1038/nrrheum.2015.135.
McCoy AM. Animal models of osteoarthritis: comparisons and key considerations. Vet Pathol. 2015;52(5):803–18. https://doi.org/10.1177/0300985815588611.
Kuyinu EL, Narayanan G, Nair LS, Laurencin CT. Animal models of osteoarthritis: classification, update, and measurement of outcomes. J Orthop Surg Res. 2016;11:19. https://doi.org/10.1186/s13018-016-0346-5.
Johnson CI, Argyle DJ, Clements DN. In vitro models for the study of osteoarthritis. Vet J. 2016;209:40–9. https://doi.org/10.1016/j.tvjl.2015.07.011.
Xu K, He Y, Moqbel SAA, Zhou X, Wu L, Bao J. SIRT3 ameliorates osteoarthritis via regulating chondrocyte autophagy and apoptosis through the PI3K/Akt/mTOR pathway. Int J Biol Macromol. 2021;175:351–60. https://doi.org/10.1016/j.ijbiomac.2021.02.029.
Tao T, Luo D, Gao C, et al. Src homology 2 domain-containing protein tyrosine phosphatase promotes inflammation and accelerates osteoarthritis by activating beta-catenin. Front Cell Dev Biol. 2021;9: 646386. https://doi.org/10.3389/fcell.2021.646386.
Wang X, Xue Y, Ye W, et al. The MEK-ERK1/2 signaling pathway regulates hyaline cartilage formation and the redifferentiation of dedifferentiated chondrocytes in vitro. Am J Transl Res. 2018;10(10):3068–85.
Chen J, Chu Y, Cao J, Yang Z, Guo X, Wang Z. T-2 toxin induces apoptosis, and selenium partly blocks, T-2 toxin induced apoptosis in chondrocytes through modulation of the Bax/Bcl-2 ratio. Food Chem Toxicol. 2006;44(4):567–73. https://doi.org/10.1016/j.fct.2005.09.004.
Qiu WJ, Xu MZ, Zhu XD, Ji YH. MicroRNA-27a alleviates IL-1beta-induced inflammatory response and articular cartilage degradation via TLR4/NF-kappaB signaling pathway in articular chondrocytes. Int Immunopharmacol. 2019;76: 105839. https://doi.org/10.1016/j.intimp.2019.105839.
Cunningham CC, Mills E, Mielke LA, et al. Osteoarthritis-associated basic calcium phosphate crystals induce pro-inflammatory cytokines and damage-associated molecules via activation of Syk and PI3 kinase. Clin Immunol. 2012;144(3):228–36. https://doi.org/10.1016/j.clim.2012.06.007.
Nees TA, Rosshirt N, Zhang JA, et al. Synovial cytokines significantly correlate with osteoarthritis-related knee pain and disability: inflammatory mediators of potential clinical relevance. J Clin Med. 2019;8(9):66. https://doi.org/10.3390/jcm8091343.
Cabrero-de Las Heras S, Martinez-Balibrea E. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer. World J Gastroenterol. 2018;24(42):4738–49. https://doi.org/10.3748/wjg.v24.i42.4738.
Hou SM, Chen PC, Lin CM, Fang ML, Chi MC, Liu JF. CXCL1 contributes to IL-6 expression in osteoarthritis and rheumatoid arthritis synovial fibroblasts by CXCR2, c-Raf, MAPK, and AP-1 pathway. Arthritis Res Ther. 2020;22(1):251. https://doi.org/10.1186/s13075-020-02331-8.
Schlichting N, Dehne T, Mans K, et al. Suitability of porcine chondrocyte micromass culture to model osteoarthritis in vitro. Mol Pharm. 2014;11(7):2092–105. https://doi.org/10.1021/mp5000554.
Shoukri B, Prieto JC, Ruellas A, et al. Minimally invasive approach for diagnosing TMJ osteoarthritis. J Dent Res. 2019;98(10):1103–11. https://doi.org/10.1177/0022034519865187.
Santamaria S, Nuti E, Cercignani G, et al. N-O-isopropyl sulfonamido-based hydroxamates: kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors. Biochem Pharmacol. 2012;84(6):813–20. https://doi.org/10.1016/j.bcp.2012.06.026.
Gosset M, Pigenet A, Salvat C, Berenbaum F, Jacques C. Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1. J Immunol. 2010;185(10):6244–52. https://doi.org/10.4049/jimmunol.0903315.
Mayer U, Benditz A, Grassel S. miR-29b regulates expression of collagens I and III in chondrogenically differentiating BMSC in an osteoarthritic environment. Sci Rep. 2017;7(1):13297. https://doi.org/10.1038/s41598-017-13567-x.
Baskey SJ, Andreana M, Lanteigne E, Ridsdale A, Stolow A, Schweitzer ME. Pre-clinical translation of second harmonic microscopy of meniscal and articular cartilage using a prototype nonlinear microendoscope. IEEE J Transl Eng Health Med. 2019;7:1800211. https://doi.org/10.1109/JTEHM.2018.2889496.
Imagawa K, de Andres MC, Hashimoto K, et al. Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation. Arthritis Rheumatol. 2014;66(11):3040–51. https://doi.org/10.1002/art.38774.
Yousef EM, Furrer D, Laperriere DL, et al. MCM2: an alternative to Ki-67 for measuring breast cancer cell proliferation. Mod Pathol. 2017;30(5):682–97. https://doi.org/10.1038/modpathol.2016.231.
Su Z, Zheng X, Zhang X, et al. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5. J Dermatol Sci. 2017;85(3):216–25. https://doi.org/10.1016/j.jdermsci.2016.12.002.
Choe KN, Moldovan GL. Forging ahead through darkness: PCNA, still the principal conductor at the replication fork. Mol Cell. 2017;65(3):380–92. https://doi.org/10.1016/j.molcel.2016.12.020.
Laphanuwat P, Likasitwatanakul P, Sittithumcharee G, et al. Cyclin D1 depletion interferes with oxidative balance and promotes cancer cell senescence. J Cell Sci. 2018. https://doi.org/10.1242/jcs.214726.
Freund A, Laberge RM, Demaria M, Campisi J. Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell. 2012;23(11):2066–75. https://doi.org/10.1091/mbc.E11-10-0884.
Xue JF, Shi ZM, Zou J, Li XL. Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis. Biomed Pharmacother. 2017;89:1252–61. https://doi.org/10.1016/j.biopha.2017.01.130.
Gao GC, Cheng XG, Wei QQ, Chen WC, Huang WZ. Long noncoding RNA MALAT-1 inhibits apoptosis and matrix metabolism disorder in interleukin-1beta-induced inflammation in articular chondrocytes via the JNK signaling pathway. J Cell Biochem. 2019;120(10):17167–79. https://doi.org/10.1002/jcb.28977.
Yang B, Ni J, Long H, Huang J, Yang C, Huang X. IL-1beta-induced miR-34a up-regulation inhibits Cyr61 to modulate osteoarthritis chondrocyte proliferation through ADAMTS-4. J Cell Biochem. 2018;119(10):7959–70. https://doi.org/10.1002/jcb.26600.
Xiao D, Bi R, Liu X, Mei J, Jiang N, Zhu S. Notch signaling regulates MMP-13 expression via Runx2 in chondrocytes. Sci Rep. 2019;9(1):15596. https://doi.org/10.1038/s41598-019-52125-5.
Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther. 2009;11(3):224. https://doi.org/10.1186/ar2592.
Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum. 2001;44(12):2777–89. https://doi.org/10.1002/1529-0131(200112)44:12%3c2777::aid-art465%3e3.0.co;2-h.
Koelling S, Kruegel J, Irmer M, et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell. 2009;4(4):324–35. https://doi.org/10.1016/j.stem.2009.01.015.
Varela-Eirin M, Loureiro J, Fonseca E, et al. Cartilage regeneration and ageing: Targeting cellular plasticity in osteoarthritis. Ageing Res Rev. 2018;42:56–71. https://doi.org/10.1016/j.arr.2017.12.006.
Johnson WEB, Ashton BA, Kwan A, Roberts S. In vitro manipulation of human chondrocyte and intervertebral disc cell morphology. Int J Exp Pathol. 2000;81(1):A16–7.
This study was supported by the National Natural Science Foundation of China (81902306), the National Key R&D Program of China (Grant No. 2018YFC2001600), and Engineering Research Center of Traditional Chinese Medicine Intelligent Rehabilitation, Ministry of Education.
Ethics approval and consent to participate
This study was approved by the Experimental Animal Welfare and Ethics Committee of Shanghai University of Traditional Chinese Medicine and adhered to the relevant laws and regulations of experimental animal welfare ethics. The ethical approval number is PZSHUTCM200710008.
Consent for publication
The authors declare that they have no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A list of 635 genes with similar expression patterns in rats and mice.
A list of 4083 differentially expressed genes in rats and mice.
A list of 52 differential expressed genes belonging to the “cell cycle” signaling pathway.
Number of published reports on cell models of osteoarthritis.
About this article
Cite this article
Ding, DF., Xue, Y., Zhang, JP. et al. Similarities and differences between rat and mouse chondrocyte gene expression induced by IL-1β. J Orthop Surg Res 17, 70 (2022). https://doi.org/10.1186/s13018-021-02889-2
- Chondrocyte inflammatory model
- RNA-seq, Differentially expressed gene